Business UpdateAug 4, 2026, 04:33 PM
SNDL Completes EU-GMP Audit at Atholville Facility
AI Summary
SNDL Inc. announced the successful completion of a European Union Good Manufacturing Practice (EU-GMP) audit at its Atholville, New Brunswick cultivation facility. This achievement reinforces SNDL’s ability to participate in regulated international medical cannabis markets and highlights its focus on quality and regulatory compliance. The company expects to receive EU-GMP certification within 90 days, strengthening Atholville's position as a key asset for international opportunities.
Key Highlights
- SNDL successfully completed an EU-GMP audit at its Atholville, New Brunswick cultivation facility.
- The company anticipates receiving EU-GMP certification for the Atholville facility within 90 days.
- The Atholville facility is 380,000 square feet with over 110,000 square feet of cultivation canopy.
- Current production capacity supports approximately 4,500 kilograms per quarter.
- The facility has the potential to support greater than 30 tonnes with targeted investment.
Price Impact
More from SNDL
Quarterly ResultJul 28, 6:58 AM
SNDL Q2 Revenue $235.8M, Operating Loss $(7.8)M; Parallel Restructuring Completed
Quarterly ResultJul 28, 6:07 AM
SNDL Gains Majority Economic Exposure to Parallel; Q2 Net Loss $(7.8M)
AcquisitionsJul 27, 12:06 PM
SNDL Completes Parallel Asset Acquisition, Expands US Cannabis Ops